• Huateng Pharma Unveils Y-Shape PEG NHS for Enhanced Drug PEGylation

    Jul 23, 2024, 08:17 by
    Huateng Pharma has launched Y-Shape PEG NHS, an advanced PEGylation solution that enhances protein drug development by improving water solubility and biocompatibility through efficient and selective modification of proteins.
    Full story
  • ‘Biolyst Scientific’ Announced as New Brand Name to Encompass EMS and Azer, Will Deepen Offerings to Clinical and Research Lab Customers

    Jul 23, 2024, 08:17 by
    Biolyst Scientific today announced its new brand name, reflecting the integration of Electron Microscopy Sciences (EMS) and Azer Scientific.
    Full story
  • Revolutionizing Clinical Trials with Generative AI

    Jul 19, 2024, 05:00 by User Not Found
    Clinical Research News | The rapid advancements in artificial intelligence, particularly generative AI (GenAI), are enabling broader technology acceleration and driving a significant transformation in the healthcare industry. This democratization of AI capabilities opens the door to widespread innovation across clinical trials and drug development and represents a unique change in thinking compared to previous technological advancements.
    Full story
  • Envision Pharma Group launches 4Sight to drive AI and technology performance in healthcare

    Jul 18, 2024, 07:50 by
    One of the world's leading providers of technology solutions Envision Pharma Group has announced the launch of 4Sight, a new form of AI-enabled technology to unlock the full potential of data and insights in medical affairs.
    Full story
  • BOC Sciences Chemistry Scholarship Program of 2024 Announced

    Jul 18, 2024, 07:50 by
    BOC Sciences is pleased to announce its new Scholarship Program aimed at supporting college students pursuing degrees in chemistry-related fields. This prestigious scholarship awards $1,000 annually to help these aspiring chemists achieve their academic goals and make a difference in the scientific community.
    Full story
  • Children’s Hospital Colorado Launches Research Institute For Children’s Health

    Jul 17, 2024, 05:00 by User Not Found
    Clinical Research News | After more than 50 years of working together, Children’s Hospital Colorado has established a formal partnership with University of Colorado Anschutz Medical Campus to launch the Colorado Child Health Research Institute. The Institute aims to unite more than 500 physician-scientists, researchers, nurse-scientists, and other investigators and enable them to develop treatments that improve the lives and health of child patients.
    Full story
  • Avallano releases ProtocolCopilot™: Powering Clinical Research with AI-driven Protocol Assistance

    Jul 16, 2024, 08:45 by
    Avallano is launching ProtocolCopilot™, an innovative AI-driven clinical research protocol assistant designed to transform the way biopharmaceutical companies and clinical research sites manage and interact with complex clinical trial protocols.
    Full story
  • Upperton Pharma Solutions Adds Large-Scale Processing following MHRA Approval at Nottingham Facility.

    Jul 16, 2024, 08:45 by
    Upperton Pharma Solutions, a UK-based contract development and manufacturing organisation (CDMO), is pleased to announce the successful completion of a Medicines and Healthcare products Regulatory Agency (MHRA) inspection at its newly commissioned 50,000 sq ft development and GMP manufacturing facility in Nottingham, UK.
    Full story
  • AXSENDO CLINICAL LAUNCHES FLAGSHIP RESEARCH SITE IN HOUSTON

    Jul 16, 2024, 08:45 by
    About Axsendo Clinical Research Axsendo Clinical Research is a national site network, bringing together top physician investigators, sponsors, and CROs to meet the needs of patients everywhere through greater access to live saving drug therapies and medical devices. ACR offers access to a wide range of facility types including dedicated research sites, surgery centers, specialties hospitals, and more. Learn more about ACR by visiting our website at www.AxsendoClinicalResearch.com ###
    Full story
  • Digital Endpoints Gaining Ground in Industry-Sponsored Trials

    Jul 16, 2024, 05:00 by User Not Found
    Clinical Research News | A recent analysis of interventional clinical trials by the Tufts Center for the Study of Drug Development (CSDD) has found that use of digital endpoints has been growing rapidly since 2015 with drug developers now initiating an average of about 35 such studies each year. News of the uptick isn’t entirely surprising, given mounting evidence that the approach can improve operational performance and ease patient burdens in clinical trials and in clinical practice, while [potentially] yielding financial net benefits to developers.
    Full story
  • Oracle Advances Safety Case Management for Life Science Organizations

    Jul 11, 2024, 07:44 by
    Oracle announced new capabilities in its AI-supported Oracle Argus and Safety One Intake solutions to help life science organizations meet evolving regulatory requirements and the rising volume of adverse event case workloads. With new enhancements designed to increase productivity, improve data privacy, and enhance reporting, users can more efficiently address dynamic, country-specific regulations and requirements, and speed the reliability and transparency of safety case management from clinical trials through post-marketing surveillance.
    Full story
  • Synexa Life Sciences Enrols in My Green Lab Certification Program

    Jul 11, 2024, 07:44 by
    Synexa Life Sciences has announced its enrolment in the My Green Lab Certification Program.
    Full story
  • Fresh Take on How to Conduct Rare Disease Clinical Trials

    Jul 11, 2024, 05:00 by User Not Found
    Clinical Research News | A boutique clinical trial program launched less than two years ago to redirect the way clinical trials for rare diseases are conducted now knows it “vastly underestimated” demand. Uncommon Cures, a privately held U.S. company, already has eight signed contracts, is negotiating five more, and is actively talking with more than 50 clients about possible trials.
    Full story
  • Pascal Piedbois, MD, PhD joins One2Treat as Chief Medical Officer to advance patient-centric innovation in clinical trial design and market access.

    Jul 10, 2024, 06:49 by
    Pascal Piedbois, MD, PhD joins One2Treat as Chief Medical Officer to advance patient-centric innovation in clinical trial design and market access. One2Treat reflects patient priorities in a single multi-facet treatment assessment, reducing trial sample size and accelerating patient access to new treatments.
    Full story
  • Proscia, Nucleai Partner to Link Digital Pathology, AI-Predictive Biomarker Platforms

    Jul 9, 2024, 05:00 by User Not Found
    Clinical Research News | Proscia and Nucleai are partnering to integrate Nucleai’s predictive biomarker solutions into Proscia’s Concentriq software platform and make them available as part of Proscia’s AI-enabled pathology portfolio to better inform patient care.
    Full story
  • CPHI South East Asia opens as growth prospects outlined for pharmaceutical development in Vietnam, Thailand and Cambodia

    Jul 8, 2024, 08:37 by
    Full story
  • ChargePoint Technology strengthens its global presence by establishing a localised team in India to support the growing pharma manufacturing market

    Jul 8, 2024, 08:37 by
    Full story
  • Indica Labs Expands Availability of HALO Digital Pathology Solutions in Asia Pacific Region Including CE-IVDR Marked HALO AP® Platform

    Jul 3, 2024, 07:11 by
    Indica Labs today announces the expansion of their reseller network in the Asia Pacific (APAC) region.
    Full story
  • FDA Releases New Draft Guidance on Diversity Action Plans for Clinical Studies

    Jul 2, 2024, 07:45 by User Not Found
    Clinical Research News | Last week, the U.S. Food and Drug Administration issued a draft guidance, “Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Studies,” to assist medical product sponsors in submitting Diversity Action Plans to support certain clinical studies. Comments on the draft guidance should be submitted by September 26, 2024.
    Full story
  • Greenphire Launches Industry’s First Patient Experience Dataset Transforming Clinical Trial Planning and Providing a View Into the Patient Journey

    Jun 28, 2024, 07:46 by
    Greenphire announced the launch of their new Patient Experience Dataset.
    Full story
  • «
  • 41
  • 42
  • 43
  • 44 (current)
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • »